Skip to main content
. 2009 Oct 21;298(1):F142–F149. doi: 10.1152/ajprenal.00320.2009

Fig. 5.

Fig. 5.

Non-smad TGF-β signaling is required for in vivo collagen III accumulation. Representative immunofluorescence sections of control and UUO kidneys stained with anti-collagen III. The bar graph displays quantification of immunoreactive renal interstitial collagen III; n = 6 each. *P < 0.05 vs. control. **P < 0.05 vs. 50 mg/kg imatinib or 1.5 mg/kg rapamycin.

HHS Vulnerability Disclosure